Isis Pharmaceuticals/ Ionis Pharmaceuticals
Isis Pharmaceuticals Inc, now renamed Ionis Pharmaceuticals is engaged in researching and developing novel human therapeutic compounds.
The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.
The company is focused on developing drugs for severe and rare diseases.
Latest Isis Pharmaceuticals/ Ionis Pharmaceuticals News & Features
17 May 2024
14 March 2024
23 January 2024
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze